Favorable quarterly results from several buy-rated stocks have rolled in this week with now appearing to be an ideal time to invest in their growth. These three top-rated stocks stand out in particular as earnings estimate revisions are likely to trend higher following their quarterly reports on Tuesday. Interactive Brokers IBKR Zacks Rank #1 (Strong Buy) Higher trading volumes helped securities exchange operator Interactive Brokers reach records in quarterly revenue and net interest income of $1.23 billion and $792 million respectively. Despite slightly missing sales estimates of $1.24 billion, Interactive Brokers’ top line expanded 23% from $1 billion in the prior-year quarter. Plus, Q2 EPS of $1.76 beat expectations by 4% and climbed 33% from $1.32 per share a year ago. Interactive Brokers attributed the record quarter to rising equity markets and the anticipation of lower rates which led to clients feeling more comfortable with taking on risk. Notably, Interactive Brokers' client credit balances hit a peak of $107.1 billion even with trading volumes indicating its users were heavily invested in markets. Zacks Investment Research Image Source: Zacks Investment Research Omnicom Group OMC Zacks Rank #2 (Buy) Advertising giant Omnicom Group had a very promising second quarter pointing to its cash flow which the company says supported its primary use of cash for dividends, acquisitions, and repurchases. Omnicom also highlighted the progress and expansion of its end-to-end generative AI solution and the growth of its e-commerce offerings. Exceeding top and bottom line expectations, Omnicom posted Q2 sales of $3.85 billion which beat estimates by 1% while EPS of $1.95 came in 4% better than expected. Year over Year, Q2 sales rose 7% with EPS spiking 8% from $1.81 a share in the comparative quarter. Zacks Investment Research Image Source: Zacks Investment Research Aehr Test Systems AEHR Zacks Rank #2 (Buy) Rounding out the list, Aehr Test Systems is a tech stock that is starting to turn heads after posting EPS of $0.84 for its fiscal fourth quarter which crushed the Zacks Consensus of $0.11 a share. Notably, Aehr’s stock spiked +22% today as the electronics testing and equipment provider ended fiscal 2024 with record revenue of $66.2 million. Wafer-level tests and burn-in of silicon carbide power semiconductors used in electric vehicles have been a key driver of Aehr’s business and the company sees emerging opportunities in new target markets. Aehr expects bookings and revenue across a much broader range of customers in FY25 with new markets including quality, reliability, and production tests of artificial intelligence processors, and flash memory devices along with various semiconductor and solar power products between chipsets and processors. Zacks Investment Research Image Source: Zacks Investment Research Bottom Line Interactive Brokers, Omnicom Group, and Aehr Test Systems are three of the most intriguing stocks to consider following their favorable quarterly results. More importantly, these companies are shaping up to be viable investments for 2024 and beyond. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omnicom Group Inc. (OMC):Free Stock Analysis Report Interactive Brokers Group, Inc. (IBKR):Free Stock Analysis Report Aehr Test Systems (AEHR):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
3 Buy Rated Stocks to Consider After Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...